Model Checkpoint Epoch: 2.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 16
	QLoRA Alpha: 24.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is an independent risk factor for neonatal morbidity. It is a more robust predictor than birth weight percentile and may be more useful in identifying at-risk infants. Measuring BF% should be considered as part of routine care in neonatal units. In addition, further studies are needed to determine whether lowering BF% in newborns can reduce their risk of developing morbidity. This would have important implications for nutritional management of newborns. © 2016 John Wiley & Sons Ltd.
Keywords: body fat percentage; neonatal outcomes; newborn screening; undernutrition.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.8
Reasoning:
The response correctly states that low BF% is independently associated with neonatal morbidity and that BF% appears to be a stronger predictor than birth weight percentiles (the study showed a larger effect size for BF%). It also appropriately calls for further research. However, it slightly overreaches by recommending routine BF% measurement in neonatal units—this study shows an association and better discrimination but does not by itself establish that routine implementation is warranted (cost, feasibility, and impact on outcomes were not addressed). The answer also omits the useful nuance that BF% can identify appropriately grown yet undernourished neonates and exclude small neonates who are not at risk.

conciseness: 0.8
Reasoning:
The response is concise and directly answers the question: it states that low BF% is an independent risk factor and a stronger predictor of neonatal morbidity than birth weight percentiles. It adds a brief recommendation and a note about needed further research; the recommendation and citation are slightly beyond the minimal direct answer but do not make the reply verbose.

relevance: 0.5
Reasoning:
The assistant’s reply does answer the question concisely (it asserts that low BF% is an independent risk factor and a better predictor than birth weight percentile), so it is relevant to the prompt and consistent with the study’s overall conclusion. However, it fails to cite or quote specific results from the provided context (no ORs, no prevalence numbers, no exact phrasing such as “more closely associated with identification of neonates at risk”), includes an incorrect or confusing recommendation about “lowering BF%” (which contradicts the aim of reducing undernutrition), and adds extraneous material (copyright/keywords) and an arguably premature clinical recommendation to add BF% to routine care without acknowledging feasibility or limitations. For these reasons the response is partially relevant but flawed in accuracy and sourcing.

coherence: 0.6
Reasoning:
The response is concise and directly answers the question by stating that low BF% is a stronger predictor of neonatal morbidity than birth weight percentiles and that BF% measurement could help identify at-risk infants. It is generally coherent and organized, but has a few problems: it includes an internally inconsistent/incorrect phrase ("determine whether lowering BF% in newborns can reduce their risk"), offers a strong recommendation for routine BF% measurement without citing the study's numeric results or acknowledging practicality/limitations, and appends irrelevant copyright/keyword lines. Overall, it answers the question clearly but with minor coherence and completeness issues.

helpfulness: 0.6
Reasoning:
The response correctly concludes that low BF% is a better predictor of neonatal morbidity than birth weight percentiles and answers the question directly. However, it has several problems: it overstates implications (recommending routine BF% measurement based on a single study without caveats), omits key supporting data (effect sizes, prevalence, and how BF% was defined), and contains a factual/wording error (“determine whether lowering BF% … can reduce their risk” is backwards). It also includes irrelevant copyright/keyword text. Overall the reply is concise and directionally correct but lacks nuance, evidence detail, and contains at least one misleading sentence.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The combination of endovascular, surgical and orthopedic treatment in patients affected by ischemic Charcot neuroarthropathy in combination with critical limb ischemia seems to be an effective method to achieve limb salvage in this group of patients. However, it must be considered as a complex treatment protocol. Further prospective studies are necessary to confirm these results. Moreover, we think that the diagnosis of ischemic Charcot foot should be taken into account in the daily practice of vascular surgeons and orthopedic surgeons, because this condition represents a new challenge in the management of lower limb arterial disease. We suggest that the term "ischemic Charcot foot" should be introduced in the clinical practice and the medical literature. Finally, the diagnosis of ischemic Charcot foot should be included in the classification of diabetic foot syndrome.
Maintenance of peripheral artery disease and the risk of cardiovascular events: does diabetes matter?
[INST] <<SYS>>
We retrospectively collected and analyzed data of all diabetic patients affected by ischemic Charcot neuropathy in combination with critical limb ischemia, who arrived to our center for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment. The limb salvage rate was 90% avoiding major amputation in 9 patients. The required time to heal the lesion was in mean 197.4±22.4 days after revascularization, surgical and orthopedic treatment.
[/INST]
In conclusion, we believe that the presence of ischemic Charcot foot in patients affected by diabetes mellitus should be considered as a new factor that may affect the outcome of the treatment of the diabetic foot. This is important because it can have a significant impact on the decision making process during the treatment of the diabetic foot. Furthermore, the term "ischemic Charcot foot" should be introduced in the daily practice of vascular surgeons and orthopedic surgeons, and also in the medical literature. Finally, the diagnosis of ischemic Charcot foot should be included in the classification of diabetic foot syndrome.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.9
Reasoning:
The assistant's reply correctly conveys that ischemic Charcot foot is a distinct and challenging presentation that benefits from combined revascularization plus surgical/orthopedic care, and it cites the reported 90% limb salvage and healing time from the case series. It appropriately notes the complexity of treatment and the need for further prospective study. Minor flaws are repetition, an unrelated stray sentence, and a somewhat opinionated recommendation to formally introduce the term and change classification based on a small retrospective series.

conciseness: 0.4
Reasoning:
The response conveys the main conclusion (combined endovascular, surgical and orthopedic treatment can achieve high limb-salvage rates in ischemic Charcot foot and the condition merits clinical recognition), but it is not concise. It repeats the same points multiple times, includes a stray/irrelevant line, and misses a short, direct answer to the question (e.g., "Yes — ischemic Charcot foot is a distinct presentation that often requires revascularization in addition to standard Charcot care; in this series limb salvage was 90% with mean healing time ~197 days"). It could be tightened to one or two clear sentences with the key data and recommendations.

relevance: 0.8
Reasoning:
The assistant's reply is relevant to the question: it acknowledges ischemic Charcot foot as a distinct clinical challenge and recommends combined endovascular, surgical and orthopedic treatment, mirroring the study's reported limb-salvage outcome. It refers to the study context and its conclusions (including advocating for recognition of "ischemic Charcot foot" in practice). Shortcomings: it repeats conclusions without explicitly quoting key outcome numbers in the main response, and makes forward-looking recommendations (introducing a new term and classification change) that go beyond the limited retrospective sample without noting the small cohort size.

coherence: 0.6
Reasoning:
The assistant’s reply is partially coherent: it addresses the core idea that ischemic Charcot foot requires combined endovascular, surgical and orthopedic management and that recognizing the condition (and the term) in clinical practice could be useful. Strengths: it summarizes outcomes (limb salvage), emphasizes complexity and need for further study, and recommends formal recognition. Weaknesses: the answer is repetitive and slightly disorganized, contains an out-of-place sentence fragment, and stops short of clearly answering whether ischemic Charcot foot is a distinct disease entity with distinct treatment—providing suggestions but little focused rationale or specific guidance. Overall, it communicates relevant points but could be clearer and better structured.

helpfulness: 0.6
Reasoning:
The assistant's reply is generally aligned with the ground truth: it highlights that combined endovascular (revascularization), surgical, and orthopedic treatment can achieve high limb-salvage rates in ischemic Charcot foot and therefore that revascularization is important to support limb- and foot-salvage. However, the response is repetitive, somewhat speculative (calling for a new disease label and classification without strong supporting discussion), and omits important limitations of the evidence (very small retrospective series, lack of controls, generalizability, technical details and timing of revascularization). It also fails to directly answer whether ischemic Charcot foot is a distinct disease entity versus a phenotypic complication and gives little practical guidance for clinicians. Overall the answer is moderately helpful but lacks depth, critical appraisal, and clarity.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Although there were no significant differences in clinical outcomes among the three groups, RH may be considered to be indicated for patients with suspected gross cervical involvement because it allows a more accurate assessment of the tumor extent, which might lead to better treatment decisions. However, further studies should be required to confirm this hypothesis. This study also suggests that RH is associated with more severe postoperative complications than mRH or SH. Thus, RH should be performed carefully and with appropriate precautions. To clarify the optimal management strategy for patients with endometrial cancer with suspected cervical involvement, prospective randomized controlled trials are necessary. Furthermore, the role of adjuvant therapies in such patients needs to be investigated. In conclusion, RH may be considered to be indicated for patients with suspected gross cervical involvement. However, further studies are required to support our findings. This trial was registered at the University Hospital Medical Information Network Clinical Trials Registry (UMIN000005368). © 2014 Japanese Society of Gynecologic Oncology. Published by John Wiley & Sons Ltd.
[/INST]
Endometrial cancer
Cervix uteri

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.3
Reasoning:
Short explanation:
The assistant's reply correctly notes that radical hysterectomy (RH) is associated with more complications and that further prospective studies are needed. However, it is misleading and partly incorrect about the study's implications because it explicitly recommends that RH "may be considered to be indicated" for patients with suspected gross cervical involvement despite the study finding no survival benefit and that type of hysterectomy was not an independent prognostic factor. The suggestion that RH is preferable because it permits more accurate tumor assessment is speculation not supported by the reported results and contradicts the study's primary conclusion that RH did not improve outcomes. Overall the response mixes accurate points (adverse events, need for trials) with an unsupported clinical recommendation.

conciseness: 0.3
Reasoning:
The response is not concise. It repeats the conclusion that RH "may be considered" multiple times, includes extraneous registry/copyright text, and adds speculative rationale (RH allows more accurate assessment) that contradicts the study’s main finding that type of hysterectomy was not an independent prognostic factor and that RH showed more complications. Overall it is wordy and contains irrelevant or misleading statements rather than a brief, to-the-point summary.

relevance: 0.3
Reasoning:
Explanation: The assistant's reply is only partially relevant to the study. It correctly notes that RH is associated with more severe postoperative complications and calls for prospective trials, which align with the study. However, the assistant repeatedly asserts that "RH may be considered to be indicated" and justifies it by saying RH allows more accurate assessment — a recommendation not supported by the presented study results, which found no survival benefit from RH and that hysterectomy type was not an independent prognostic factor. The answer therefore misinterprets the primary findings and presents an unwarranted clinical endorsement not grounded in the quoted context.

coherence: 0.6
Reasoning:
The response is organized and readable (intro, findings, cautions, and conclusion) and mostly coherent in flow. However it is repetitious and internally inconsistent with the study summary: it states there were “no significant differences” but nonetheless recommends RH as potentially indicated, without providing study-based evidence for that recommendation. Overall the structure is clear but the conclusion is unsupported and redundant.

helpfulness: 0.3
Reasoning:
Explanation: The assistant's answer correctly notes that radical hysterectomy (RH) is associated with more postoperative complications and that further prospective trials are needed. However it misrepresents the study's main finding by implying RH "may be considered" indicated because it allows more accurate assessment, despite the GOTIC-005 results showing type of hysterectomy was not an independent prognostic factor and no survival benefit for RH. The response is repetitive and draws an unsupported clinical recommendation that conflicts with the study conclusion, reducing its accuracy and usefulness.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: We found that the majority of the readmissions occurred within the first week of discharge and were associated with complications related to pancreatic fistulas or abdominal sepsis. These complications are amenable to intervention. Strategies to improve perioperative care and reduce postoperative complications may help decrease readmissions after PD. We recommend that all institutions should track their readmissions rates and identify the most important risk factors to develop strategies to reduce readmissions. Patients who require readmissions should be counseled about these potential risks before being discharged home. Furthermore, efforts to optimize perioperative care will probably result in improved survival and lower health-care costs. Future studies should focus on the cost-effectiveness of such interventions. Finally, further work is needed to understand how best to measure readmissions and what metrics would best reflect the quality of care provided by surgeons. The use of readmissions as a metric for measuring quality of care should be abandoned because it is a flawed measurement tool. Instead, we should focus on the development of validated measures that capture patient outcomes. The National Quality Forum recently recommended that the Centers for Medicare & Medicaid Services adopt a set of metrics that are based on the concept of "patient centeredness." Our results suggest that the readmission rate is not an adequate measure of quality. Surgeons should strive to provide patient-centered care, which means that the patient's needs must be paramount when making decisions about care. This approach has the potential to reduce unnecessary readmissions, improve patient satisfaction, and enhance overall health-care quality. For example, patients who require readmissions should be given a comprehensive list of medications to take, including antibiotics and pain control agents, and they should be counseled on the importance of taking their medications as directed. Furthermore, they should be told to call their primary care physician if they experience any changes in symptoms. This education will help reduce the likelihood of readmission. The development of a comprehensive national database that tracks readmissions after PD could help us better understand the causes of readmissions and identify ways to reduce them. Such a database could also provide valuable information regarding the effect of readmissions on health-care costs. In addition, future studies should investigate the relationship between readmissions and long-term survival. It is possible that readmissions are a marker for poor outcome and that patients who require readmissions are at increased risk of death. Thus, we should investigate whether readmissions are associated with long-term survival. Finally, we should continue to refine the definition of readmissions so that it accurately captures the reason for readmission. For example, a patient who requires a return trip to the emergency department for a minor procedure should not be considered a readmission. Similarly, a patient who requires a return visit for a complication related to a nonoperative condition should not be considered a readmission. Further work is needed to determine how best to define readmissions.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.4
Reasoning:
The response contains some useful, relevant suggestions (perioperative optimization, tracking readmissions, patient education) but has several problems in correctness and emphasis relative to the presented data. It incorrectly states that a "majority" of readmissions occurred within the first week (the data show 50% occurred ≤7 days), fails to mention the independent association with complexity of the initial resection (multivisceral resection), and does not appropriately prioritize preventing early readmissions as the ground-truth conclusion recommends. It also makes an unsubstantiated, strong claim that readmissions should be abandoned as a quality metric, which contradicts the context that readmission is increasingly used and is not supported by the provided results. Overall the answer mixes reasonable recommendations with inaccuracies, omissions, and unjustified opinion.

conciseness: 0.3
Reasoning:
Explanation: The response is wordy and repetitive, wanders into policy opinions (e.g., "abandon" readmission as a metric) and broad recommendations rather than succinctly addressing the study's main actionable findings. It fails to concisely highlight the key independent predictors (complex initial/multivisceral resection, pancreatic fistula, prolonged initial stay, ICU admission) or emphasize preventing early readmissions (≈50% within 7 days), instead offering many extraneous suggestions and restatements.

relevance: 0.4
Reasoning:
Explanation: The assistant's reply partially addresses the question by recommending perioperative optimization, tracking readmissions, and patient counseling, and it does refer to real findings from the context (pancreatic fistula as a cause of readmission and early readmissions within 7 days). However, it inaccurately states that a "majority" of readmissions occurred within the first week (the study reports 50%), introduces unsupported or editorial opinions (e.g., that readmissions as a quality metric "should be abandoned"), and adds many recommendations and future-research suggestions that are not grounded in the presented data. Overall the response mixes relevant points with factual imprecision and extraneous judgments.

coherence: 0.4
Reasoning:
Explanation: The response is partially coherent and offers several sensible prevention-oriented suggestions (track readmissions, optimize perioperative care, patient counseling, databases). However it contains inaccuracies and contradictions: it states a "majority" occur within a week while the study found 50% (half); it alternately recommends tracking readmissions then argues they should be abandoned as a quality metric; and it adds speculative or unsupported claims (e.g., readmissions as a marker for long-term survival) and repetitive content. Overall structure is loose and the argument is inconsistent, reducing clarity and reliability.

helpfulness: 0.4
Reasoning:
Explanation: The response contains some useful and relevant points — it identifies pancreatic fistula and early (≤7 days) readmissions as important and recommends institution-level tracking, perioperative optimization, patient counseling, and targeted interventions — all of which are reasonable prevention strategies. However, it also has important shortcomings: it inaccurately describes early readmissions as a "majority" when the study reports ~50%; it omits other independent predictors identified (complex/multivisceral resection, prolonged initial LOS, ICU admission); it introduces unsubstantiated normative claims (advocating abandonment of readmissions as a quality metric) that go beyond the study findings; and it offers repetitive, generic suggestions and speculative research priorities rather than a focused, evidence-aligned answer about preventing readmissions. Overall the reply is partially helpful but not fully accurate or tightly aligned with the ground-truth findings.

================================================================================
Average correctness Score: 0.525
Average conciseness Score: 0.375
Average relevance Score: 0.5
Average coherence Score: 0.495
Average helpfulness Score: 0.48
